LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 71.78 | 27.76 | 1122 | 6893 | 0.1628 | 0.5920 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 71.78 | 27.76 | 236 | 6893 | 0.0342 | 0.3087 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 71.78 | 27.76 | 1586 | 6893 | 0.2301 | 0.6627 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 73.48 | 27.76 | 1119 | 6957 | 0.1608 | 0.5902 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 73.48 | 27.76 | 1129 | 6957 | 0.1623 | 0.5920 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 73.48 | 27.76 | 250 | 6957 | 0.0359 | 0.3176 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 73.48 | 27.76 | 1574 | 6957 | 0.2262 | 0.6597 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 75.19 | 27.76 | 1123 | 7015 | 0.1601 | 0.5898 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 75.19 | 27.76 | 1128 | 7015 | 0.1608 | 0.5907 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 75.19 | 27.76 | 244 | 7015 | 0.0348 | 0.3130 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 75.19 | 27.76 | 1640 | 7015 | 0.2338 | 0.6670 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 76.89 | 27.76 | 1135 | 7025 | 0.1616 | 0.5917 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 76.89 | 27.76 | 1140 | 7025 | 0.1623 | 0.5926 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 76.89 | 27.76 | 249 | 7025 | 0.0354 | 0.3163 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 76.89 | 27.76 | 1655 | 7025 | 0.2356 | 0.6687 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 78.60 | 27.76 | 1132 | 7045 | 0.1607 | 0.5908 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 78.60 | 27.76 | 1141 | 7045 | 0.1619 | 0.5924 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 78.60 | 27.76 | 248 | 7045 | 0.0352 | 0.3154 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 78.60 | 27.76 | 1628 | 7045 | 0.2311 | 0.6648 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 80.31 | 27.76 | 1146 | 6976 | 0.1643 | 0.5946 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 80.31 | 27.76 | 1154 | 6976 | 0.1654 | 0.5960 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 80.31 | 27.76 | 251 | 6976 | 0.0360 | 0.3181 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 80.31 | 27.76 | 1626 | 6976 | 0.2331 | 0.6661 | MN20160318_Q01 | L22 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.01 | 27.76 | 1174 | 7000 | 0.1677 | 0.5990 | MN20160318_Q01 | D07 |
| MCF 10A-H2B-mCherry | Trametinib | 0.031623 | 82.01 | 27.76 | 1182 | 7000 | 0.1689 | 0.6003 | MN20160318_Q01 | D07 |